rdf:type |
|
lifeskim:mentions |
umls-concept:C0008902,
umls-concept:C0015491,
umls-concept:C0025344,
umls-concept:C0027627,
umls-concept:C0030705,
umls-concept:C0205314,
umls-concept:C0439828,
umls-concept:C0443268,
umls-concept:C0679622,
umls-concept:C1522577,
umls-concept:C1561960,
umls-concept:C1704243,
umls-concept:C1883712,
umls-concept:C1948053,
umls-concept:C2347804
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-1-23
|
pubmed:abstractText |
Several factors have been proven to be useful for classifying patients with papillary thyroid carcinoma (PTC) into either low- or high-risk groups. However, the relative importance of prognostic factors, including lymph nodal metastasis, remains unclear.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0039-6060
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-48
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14739848-Adolescent,
pubmed-meshheading:14739848-Adult,
pubmed-meshheading:14739848-Aged,
pubmed-meshheading:14739848-Aged, 80 and over,
pubmed-meshheading:14739848-Carcinoma, Papillary,
pubmed-meshheading:14739848-Female,
pubmed-meshheading:14739848-Follow-Up Studies,
pubmed-meshheading:14739848-Humans,
pubmed-meshheading:14739848-Male,
pubmed-meshheading:14739848-Middle Aged,
pubmed-meshheading:14739848-Multivariate Analysis,
pubmed-meshheading:14739848-Neoplasm Recurrence, Local,
pubmed-meshheading:14739848-Prognosis,
pubmed-meshheading:14739848-Risk Factors,
pubmed-meshheading:14739848-Survival Analysis,
pubmed-meshheading:14739848-Thyroid Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period.
|
pubmed:affiliation |
Division of Head and Neck, Cancer Institute Hospital, and the Department of Pathology, Cancer Institute, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|